MO · 10-Q · 2026Q2 · Full report

FDA Tobacco Product Standards

ALTRIA GROUP, INC. · 2026-07-30 · Importance 37 · Surprise 42 · In source text

The FDA proposed a January 2025 product standard that would substantially reduce nicotine levels in cigarettes, little cigars, cigarillos and most large cigars; public comments closed in September 2025 and Altria expects the rulemaking process to take multiple years. The FDA also has proposed bans on menthol cigarettes and characterizing flavors in cigars, while the Trump Administration withdrew both proposals from OMB in January 2025 and returned them to the FDA. A March 2023 proposed tobacco manufacturing-practices rule could increase compliance costs if finalized. Final product standards or enforcement actions could materially affect product sales, asset carrying values, manufacturing costs and the company’s financial position.

Key facts

• Most cigarette and smokeless tobacco products currently marketed by PM USA and USSTC are 'Provisional Products' and PM USA and USSTC timely submitted SE reports for these Provisional Products. source
• In January 2025, the FDA proposed a tobacco product standard to establish a maximum nicotine level in cigarettes and certain other combustible tobacco products; the public comment period closed in September 2025 and Altria expects the rulemaking to take multiple years to complete. source
• In April 2022 the FDA issued two proposed product standards banning menthol in cigarettes and banning all characterizing flavors in cigars; in October 2023 the FDA submitted these proposed standards to the White House OMB, and in January 2025 the Trump Administration withdrew them from OMB and sent them back to the FDA. source

Impact estimates